Please provide your email address to receive an email when new articles are posted on . A new expert consensus decision pathway published by the American College of Cardiology highlights the ...

Please provide your email address to receive an email when new articles are posted on . An AI model accurately distinguished cardiac amyloidosis from other phenotypic mimics. The model also showed ...

A month after raising $55 million to advance its AI-enhanced ultrasound diagnostics for cardiovascular disease, Ultromics Ltd. presented strong results for its U.S. FDA-cleared AI analysis of ...

Cardiac amyloidosis (CA) is a progressive infiltrative cardiomyopathy resulting from the extracellular deposition of misfolded proteins, most commonly transthyretin (ATTR) or immunoglobulin light ...

Anumana Inc. has garnered a U.S. FDA breakthrough device designation for its artificial intelligence (AI)-powered electrocardiogram-based algorithm for early identification of cardiac amyloidosis. The ...

"These forms of cardiac amyloidosis are rare but increasingly recognized. For the first time, patients with both forms of amyloidosis have undergone deep phenotyping using cardiac biomarkers, 12-lead ...

Cardiac amyloidosis is a heart condition in which abnormal proteins build up in the heart muscle, making it stiff and impairing its ability to pump blood. Multiple life-prolonging drug treatments for ...

Investigators in Italy report that CA may be underdiagnosed in women due to sex differences in left ventricular wall thickness. Current diagnostic criteria may not accurately reflect disease severity ...

Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment. Cardiac ...

After spinning up a pair of companies to commercialize remote diagnostic tools, Mayo Clinic shared the results of a study indicating an AI algorithm could be used to improve diagnosis of a certain ...